Extended Data Fig. 2: Flow cytometry gating strategies and representative plots.
From: Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
a, Gating strategy and representative flow cytometry plots for the assessment of CD4+, CD8+ and γδ T cells in Adar1-null and control B16 tumours. b, Gating strategy and representative flow cytometry plots for the assessment of NK cells in Adar1-null and control B16 tumours. c, Gating strategy and representative flow cytometry plots for the assessment of CD11b+Ly6c+ and CD11b+Ly6cloCD24+ cells in Adar1-null and control B16 tumours.
